Tumor necrosis factor-α levels in patients with HIV with wasting in South Asia

AIDS Patient Care and STDs

Volumn 19, Issue 4, 2005, Pages 212-215

  Wig, Naveet ^a   Anupama, P ^a   Singh, S ^a   Handa, R ^a   Aggarwal, P ^a   Dwivedi, S N ^a   Jailkhani, B L ^a   Wali, J P ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; CORRELATION ANALYSIS; DEVELOPING COUNTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; SOUTH ASIA; TUBERCULOSIS; WASTING SYNDROME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BIOLOGICAL MARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV WASTING SYNDROME; HUMANS; INCIDENCE; INDIA; MALE; MIDDLE AGED; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 18144430596     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2005.19.212     Document Type: Article

References (15)

1. Hommes MJ, Romijn JA, Endert, E, Sauerwein HP. Resting energy expenditure and substrate oxidation in HIV infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage. Am J Clin Nutr 1991;54:311-315.
2. Melchior J, Salmon D, Rigaud D, et al. Resting energy expenditure is increased in stable, malnourished HIV infected patients. Am J Clin Nutr 1991;53:437-441.
3. Grunfield C, Pang M, Shimizu L, Shigenaga JK, Jensen P, Feingold KR. Resting energy expenditure, caloric intake and short term weight change in HIV infection and AIDS. Am J Clin Nutr 1992;55:455-460.
4. Beutler B, Cerami A. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 1986;320:584-588.
5. Lahdevirta J, Maury CP, Teppo AM, Repo H. Elevated levels of circulating cachectin/TNF in patients with AIDS Am J Med 1988;85:289-291.
6. Oliff A, Defeo-Jones D, Boyer M, et al. Tumors secreting human TNF/cachectin induce cachexia in mice. Cell 1987;50:555-563.
7. Luke DR, McCreedy BJ, Sarnoski TP, et al. Phase I/II study of pentoxyphylline with zidovudine on HIV 1 growth in AIDS patients. Int J Clin Pharmacol Ther Toxicol 1993;31:343-350.
8. Constans J, Pellegrin JL, Peuchant E, et al. Plasma lipids in HIV infected patients: Prospective study in 95 patients. Eur J Clin Invest 1994;24:416-420.
9. Reddy MM, Sorrell SJ, Lange M, Grieco MH. Tumor necrosis factor and HTV p 24 antigen levels in serum of HIV infected population. J Acquir Immune Defic Syndr 1988;1:436-440.
10. Landman D, Sarai A, Sathe SS. Use of pentoxyphylline therapy for patients with AIDS related wasting: Pilot study. Clin Infect Dis 1994;18:97-99.
11. Dezube BJ, Ledderman M, Spritzler JG, et al. High dose pentoxyphylline in patients with AIDS: Inhibition of TNF alpha production. J Infect Dis 1995;171:1628-1632.
12. Arnalich F, Martinez P, Hernanz A, et al. Altered concentrations of appetite regulators may contribute to development and maintenance of HIV assoc wasting. AIDS 1997;11:1129-1134.
13. McNurlan M, Garlick PJ, Steigbigel RT, et al. Responsiveness of muscle protein synthesis to growth hormone administration in HIV infected individuals decline with severity of disease. J Clin Invest 1997;100:2125-2132.
14. Hellerstein MK, Wu K, McGrath M, et al. Effects of n-3 dietary fatty acid supplementation in men with weight loss associated with AIDS: Relation to indices of cytokine production. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:257-270.
15. Aukrust P, Liabakk NB, Muller F, Lien E, Espevik T, Froland SS. Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection - Correlations to clinical, immunologic, and virologic parameters. J Infect Dis 1994;169:420-424.